Zou, Q., Bai, S., Wang, L., Tong, H., Zeng, D., Zhao, Y., Shuang, Y., Wang, X., Sun, X., Hong, Z., Peng, Z., Yang, Y., Zheng, R., Huang, H., Liu, J., Yang, C., Li, X., Gao, X., Xu, H., Chen, D., Fang, X., Nie, M., Wang, J., Gao, X., Ye, J., Zhang, W., Shen, J., Tao, R., Cen, H., Zhang, Y., Cai, J., Xia, Y., Cai, Q. (2026). Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial. Nature Communications. https://doi.org/10.1038/s41467-026-74483-1